• Gefitinib (ZD1839) in Tumor Assembloids

  2026-09-15

  Use Gefitinib (ZD1839) to distinguish tumor-cell EGFR dependence from stromal protection in patient-derived gastric cancer assembloids. This workflow combines matched organoids, stromal subpopulations, phospho-EGFR readouts, and viability testing for more informative drug-response studies.

• Eltanexor (KPT-8602) Workflow for XPO1 Studies

  2026-09-15

  Build reproducible XPO1 inhibition experiments with Eltanexor (KPT-8602), from DMSO stock preparation and viability testing to nuclear-retention and Wnt/β-catenin assays. The workflow connects hematologic cancer models with colorectal organoids and Apcmin/+ studies while emphasizing exposure control, assay selection, and troubleshooting.

• Kitasamycin Biosynthesis in Leucine-Resistant Mutants

  2026-09-14

  The reference study shows that precursor feeding and leucine-analog selection can redirect kitasamycin biosynthesis toward the more potent A1/A3 components in Streptomyces kitasatoensis. Its main practical contribution is linking altered amino-acid regulation to antibiotic-complex composition, a useful framework for strain engineering and antibacterial drug discovery.

• 4-MUG for Lysosomal Enzyme Assays

  2026-09-14

  4-Methylumbelliferyl-β-D-Glucopyranoside, also called 4-MUG, is a fluorogenic substrate for β-glucosidase and β-glucocerebrosidase activity assays. Enzymatic hydrolysis releases 4-methylumbelliferone, enabling sensitive fluorescence-based measurements in lysosomal and Gaucher disease research.

• EdU Imaging Kits (HF594) for PNI Research

  2026-09-13

  EdU Imaging Kits (HF594) provide a precise DNA synthesis measurement strategy for pancreatic cancer–nerve models. This article explains how to use S-phase labeling to separate tumor-cell proliferation from Schwann-cell remodeling in perineural invasion research.

• Perospirone Blocks Kv1.5 in Coronary Myocytes

  2026-09-12

  The reference study identifies a previously unrecognized vascular ion-channel action of Perospirone: concentration-dependent inhibition of voltage-gated K+ currents in freshly isolated rabbit coronary arterial smooth muscle cells. Pharmacological profiling implicates Kv1.5 channels and suggests a use-independent mechanism, extending the antipsychotic drug mechanism of Perospirone into cardiovascular safety research without establishing clinical vascular effects.

• TAM EV miR-660 Drives Breast Cancer Metastasis

  2026-09-11

  The reference study shows that tumor-associated macrophage-derived extracellular vesicles transfer miR-660 into breast cancer cells, where it suppresses KLHL21-mediated restraint of IKKβ/NF-κB p65 signaling and promotes invasion and metastasis. Its main contribution is a linked cellular-to-molecular model that connects macrophage communication, post-transcriptional regulation, and metastatic behavior.

• CHIR 99021 Trihydrochloride for Reliable Assays

  2026-09-11

  This scenario-based guide explains how CHIR 99021 trihydrochloride, SKU B5779, can improve experimental planning for cell viability, proliferation, cytotoxicity, organoid, and metabolic studies. It covers GSK-3 selectivity, concentration design, formulation compatibility, data interpretation, and practical supplier evaluation.

• 7-Ethyl-10-hydroxycamptothecin Assay Guide

  2026-09-10

  A scenario-based guide to using 7-Ethyl-10-hydroxycamptothecin, SKU N2133, in viability, proliferation, cytotoxicity, cell-cycle, and apoptosis workflows. It connects the compound’s reported 77 nM topoisomerase I inhibition value with practical solvent, storage, interpretation, and vendor-selection decisions.

• Lapatinib: From Kinase Potency to Translational Proof

  2026-09-10

  Lapatinib, also known as GW572016, offers a rigorous bridge from EGFR and HER2 kinase inhibition to cell-cycle, proliferation, invasion, and angiogenesis phenotypes. This translational framework shows how to use receptor context, combination designs, and phenotype-first assays without confusing biochemical potency with therapeutic efficacy.

• Epinephrine Bitartrate: From Signal to PK

  2026-09-09

  Epinephrine Bitartrate is a non-selective adrenergic receptor agonist whose value extends beyond endpoint assays. This guide connects receptor pharmacology with route-dependent pharmacokinetics, heart-rate readouts, formulation controls, and translational experimental design.

• CCK8 Workflow for Gemcitabine Sensitivity Studies

  2026-09-09

  Use cck8 to connect metabolic viability signals with treatment response in intrahepatic cholangiocarcinoma models. This practical workflow emphasizes factorial drug design, conditioned-medium experiments, assay linearity, and troubleshooting so Cell Counting Kit-8 data support—not overstate—mechanistic conclusions.

• Hesperadin for Reliable Mitotic Assays

  2026-09-08

  This scenario-led guide explains how Hesperadin, SKU A4118, can help researchers distinguish cytostatic mitotic disruption from acute cytotoxicity in cell-based assays. It combines product-backed biochemical and formulation data with practical controls for Aurora B, chromosome segregation, and spindle checkpoint studies.

• Chronic Stress, Brain Mitochondria, and MnTBAP Rescue

  2026-09-08

  A 2025 rat study links chronic unpredictable mild stress with depression-like behavior, impaired mitochondrial function, and neuroinflammatory signaling in the hippocampus and prefrontal cortex. Its key advance is the use of intracerebroventricular MnTBAP as a mechanistic probe, showing that mitochondrial redox intervention can alleviate stress-related behavioral abnormalities without establishing that oxidative stress is the sole causal pathway.

• 3X (DYKDDDDK) Peptide: Workflow & Troubleshooting

  2026-09-07

  A practical guide to using the 3X FLAG peptide for selective capture, immunodetection, metal-sensitive assays, and structural workflows. It connects tag chemistry with PRC2–chromatin experiments while emphasizing controls, buffer compatibility, and recovery optimization.

3609 records 1/241 page Next 12345 下5页 Last page